These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12601232)

  • 1. Attribution of improvement to medication and increased risk of relapse of panic disorder with agoraphobia.
    Biondi M; Picardi A
    Psychother Psychosom; 2003; 72(2):110-1; author reply 111. PubMed ID: 12601232
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined antidepressants and CBT for panic disorder with agoraphobia.
    Coupland NJ
    J Psychiatry Neurosci; 2008 Mar; 33(2):176. PubMed ID: 18330461
    [No Abstract]   [Full Text] [Related]  

  • 3. Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?
    Oei TP; Llamas M; Evans L
    Behav Res Ther; 1997 Sep; 35(9):851-7. PubMed ID: 9299805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up on the treatment of panic disorder with or without agoraphobia: a quantitative review.
    Bakker A; van Balkom AJ; Spinhoven P; Blaauw BM; van Dyck R
    J Nerv Ment Dis; 1998 Jul; 186(7):414-9. PubMed ID: 9680042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased probability of remaining in remission from panic disorder with agoraphobia after drug treatment in patients who received concurrent cognitive-behavioural therapy: a follow-up study.
    Biondi M; Picardi A
    Psychother Psychosom; 2003; 72(1):34-42. PubMed ID: 12466636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder.
    Nadiga DN; Hensley PL; Uhlenhuth EH
    Depress Anxiety; 2003; 17(2):58-64. PubMed ID: 12621593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.
    Loerch B; Graf-Morgenstern M; Hautzinger M; Schlegel S; Hain C; Sandmann J; Benkert O
    Br J Psychiatry; 1999 Mar; 174():205-12. PubMed ID: 10448444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tranylcypromine for chronic therapy-resistant agoraphobia with panic disorder and recurrent depressive disorder].
    Boerner RJ; Lühring F
    Psychiatr Prax; 2010 Oct; 37(7):350-2. PubMed ID: 20703987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety sensitivity.
    Fava GA
    Am J Psychiatry; 1996 Aug; 153(8):1109-10. PubMed ID: 8678187
    [No Abstract]   [Full Text] [Related]  

  • 10. Do panic symptoms during periods of remission predict relapse of panic disorder?
    Weisberg RB; Machan JT; Dyck IR; Keller MB
    J Nerv Ment Dis; 2002 Mar; 190(3):190-7. PubMed ID: 11923654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [JSNP Excellent Presentation Award for AsCNP 2011: an analysis of pharmacotherapy combined cognitive-behavioral group therapy for panic disorder with agoraphobia].
    Takashio O; Kokubo Y; Akita R; Tanaka H; Sakagami K; Shimizu H; Okajima Y; Nakamura D; Akashi N; Kato N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Apr; 32(2):105-7. PubMed ID: 22708267
    [No Abstract]   [Full Text] [Related]  

  • 12. [Panic disorder and agoraphobia: what is effective?].
    Bandelow B; Sievert K; Röthemeyer M; Hajak G; Broocks A; Rüther E
    Fortschr Neurol Psychiatr; 1995 Nov; 63(11):451-64. PubMed ID: 8575719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive behavioral therapy for agoraphobia.
    Knuts IJ; Esquivel G; Overbeek T; Schruers KR
    J Affect Disord; 2015 Mar; 174():19-22. PubMed ID: 25479049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical issues in the long-term treatment of panic disorder.
    Rosenbaum JF; Pollack MH; Pollock RA
    J Clin Psychiatry; 1996; 57 Suppl 10():44-8; discussion 49-50. PubMed ID: 8917131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of agoraphobia with panic disorder.
    Perugi G; Frare F; Toni C
    CNS Drugs; 2007; 21(9):741-64. PubMed ID: 17696574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of group experiential cognitive therapy for the treatment of panic disorder with agoraphobia.
    Choi YH; Vincelli F; Riva G; Wiederhold BK; Lee JH; Park KH
    Cyberpsychol Behav; 2005 Aug; 8(4):387-93. PubMed ID: 16092896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nefazodone and the treatment of panic.
    Berigan TR; Casas A; Harazin J
    J Clin Psychiatry; 1998 May; 59(5):256-7. PubMed ID: 9632040
    [No Abstract]   [Full Text] [Related]  

  • 18. Panic disorder as a chronic illness.
    Liebowitz MR
    J Clin Psychiatry; 1997; 58 Suppl 13():5-8. PubMed ID: 9402913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of medical services and treatment for panic disorder with agoraphobia and for social phobia.
    Swinson RP; Cox BJ; Woszczyna CB
    CMAJ; 1992 Sep; 147(6):878-83. PubMed ID: 1525731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating medication-resistant panic disorder: predictors and outcome of cognitive-behavior therapy in a Brazilian public hospital.
    Heldt E; Manfro GG; Kipper L; Blaya C; Maltz S; Isolan L; Hirakata VN; Otto MW
    Psychother Psychosom; 2003; 72(1):43-8. PubMed ID: 12466637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.